[PDF][PDF] Gene expression correlates of clinical prostate cancer behavior
Prostate tumors are among the most heterogeneous of cancers, both histologically and
clinically. Microarray expression analysis was used to determine whether global biological …
clinically. Microarray expression analysis was used to determine whether global biological …
Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer
Androgen receptor (AR) plays a central role in prostate cancer, and most patients respond
to androgen deprivation therapies, but they invariably relapse with a more aggressive …
to androgen deprivation therapies, but they invariably relapse with a more aggressive …
[PDF][PDF] Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression
… Febbo, Joseph R. Nevins, Anil Potti, and Kimberly L. Blackwell … Paik S, Shak S, Tang G,
et al: A multi-gene assay to predict recurrence of tamoxifen-treated, node-negative breast …
et al: A multi-gene assay to predict recurrence of tamoxifen-treated, node-negative breast …
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
PK Majumder, PG Febbo, R Bikoff, R Berger, Q Xue… - Nature medicine, 2004 - nature.com
Loss of PTEN function leads to activation of phosphoinositide 3-kinase (PI3K) signaling and
Akt. Clinical trials are now testing whether mammalian target of rapamycin (mTOR) inhibition …
Akt. Clinical trials are now testing whether mammalian target of rapamycin (mTOR) inhibition …
A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling
…, FL Baehner, D Knezevic, PG Febbo… - European urology, 2014 - Elsevier
Background Prostate tumor heterogeneity and biopsy undersampling pose challenges to
accurate, individualized risk assessment for men with localized disease. Objective To identify …
accurate, individualized risk assessment for men with localized disease. Objective To identify …
[PDF][PDF] Emergence and rapid transmission of SARS-CoV-2 B. 1.1. 7 in the United States
…, B Austin, D MacCannell, M Isaksson, PG Febbo… - Cell, 2021 - cell.com
The highly transmissible B.1.1.7 variant of SARS-CoV-2, first identified in the United Kingdom,
has gained a foothold across the world. Using S gene target failure (SGTF) and SARS-CoV…
has gained a foothold across the world. Using S gene target failure (SGTF) and SARS-CoV…
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer
Background Overexpression of the fatty acid synthase (FASN) gene has been implicated in
prostate carcinogenesis. We sought to directly assess the oncogenic potential of FASN. …
prostate carcinogenesis. We sought to directly assess the oncogenic potential of FASN. …
[PDF][PDF] Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma
…, RE McLendon, Z Wei, DW Ellison, PG Febbo… - Cancer cell, 2009 - cell.com
The growth of many cancers depends on self-renewing cells called cancer stem cells or
tumor-propagating cells (TPCs). In human brain tumors, cells expressing the stem cell marker …
tumor-propagating cells (TPCs). In human brain tumors, cells expressing the stem cell marker …
[HTML][HTML] A biopsy-based 17-gene genomic prostate score predicts recurrence after radical prostatectomy and adverse surgical pathology in a racially diverse …
…, D Knezevic, T Maddala, HJ Lawrence, PG Febbo… - European urology, 2015 - Elsevier
Background Biomarkers that are validated in independent cohorts are needed to improve
risk assessment for prostate cancer (PCa). Objective A racially diverse cohort of men (20% …
risk assessment for prostate cancer (PCa). Objective A racially diverse cohort of men (20% …
[PDF][PDF] An animal model of MYC-driven medulloblastoma
Medulloblastoma (MB) is the most common malignant brain tumor in children. Patients
whose tumors exhibit overexpression or amplification of the MYC oncogene (c-MYC) usually …
whose tumors exhibit overexpression or amplification of the MYC oncogene (c-MYC) usually …
